Cosmo Bio Company,Limited (TYO:3386)

Japan · Delayed Price · Currency is JPY

1,250.00

0.00 (0.00%)

Oct 9, 2026, 3:30 PM JST

Market Cap	7.12B +2.3%
Revenue (ttm)	11.28B +9.4%
Net Income	364.00M +43.3%
EPS	64.10 +45.0%
Shares Out	5.70M
PE Ratio	19.50
Forward PE	n/a
Dividend	50.00 (4.00%)
Ex-Dividend Date	Dec 29, 2026

Volume	2,100
Open	1,245.00
Previous Close	1,250.00
Day's Range	1,243.00 - 1,250.00
52-Week Range	1,083.00 - 1,486.00
Beta	0.19
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 6, 2026

About Cosmo Bio Company,Limited

Cosmo Bio Company,Limited, together with its subsidiaries, operates as a life science trading company worldwide. It is involved in the import, export, manufacture, marketing, sales, and customer support of life science research bio tools, such as reagents, kits, instruments, and software. The company also distributes antibodies, antigens, biologically active substances, enzymes, substrates, peptides, amino acids, chemicals, carbohydrates, lipids, virus components, and bacteria, as well as detection reagents, cell and tissue culture systems, and... [Read more]

Industry Medical - Diagnostics & Research

Sector Healthcare

Founded 1978

Employees 182

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 3386

Full Company Profile

Financial Performance

In 2025, Cosmo Bio Company,Limited's revenue was 10.77 billion, an increase of 7.26% compared to the previous year's 10.04 billion. Earnings were 337.00 million, an increase of 28.63%.

Financial Statements